Reiji Yoshimura* and Jun Nakamura
Department of Psychiatry, University of Occupational and Environmental Health, Kitakyushu, Japan
Received date: May 28, 2014; Accepted date: September 16, 2014; Published date: September 23, 2014
Citation: Nakamura J, Yoshimura R (2014) Problems for Psychotherapy Systems in Japan: A Mean to Improve Daily Clinical Examination. J Psychol Psychother 4:153. doi:10.4172/2161-0487.1000153
Copyright: © 2014 Yoshimura R et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Visit for more related articles at Journal of Psychology & Psychotherapy
In mild to moderate Major Depressive Disorder (MDD) patients, efficacy of psychotherapy is equal to that of pharmacotherapy. However, pharmacotherapy is more popular than psychotherapy for patients with MDD in Japan. One of the reasons is the increasing the number of MDD patients. Ordinary Japanese psychiatrists should examine over 50 outpatients every day. Thus, they cannot spare time at least 15 minutes for a new patient. Actually, it is difficult to perform standardized Cognitive Behavioral Therapy (CBT), interpersonal psychotherapy, and psychodynamic psychotherapy in daily clinical work within Japanese insurance system. Furthermore, costs of psychotherapy were very low compared with other countries. Sophisticated supervising systems are not established is another problematic issue. Recently, Shimodera et al.  reported that psychoeducation is effective in the relapse of MDD and seems to be more cost-effective without psychoeducation. Furukawa et al.  insisted that remote CBT, including telephoned CBT (tCBT) might be one of useful psychotherapy for people in the work place who present with sub-threshold depression. Psychotherapy using devices such as computer and smart phone combined with pharmacotherapy might be useful to increase the efficacy of outcome of the treatment for MDD. Robust verification should be done to the speculation.